ARMATA PHARMACEUTICALS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 29th, 2021 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of October 28, 2021, by and between Armata Pharmaceuticals, Inc., a Washington corporation (the “Company”), Innoviva Strategic Opportunities LLC (“Innoviva”) and Cystic Fibrosis Foundation, a Delaware corporation (“CFF” and together with Innoviva, each a “Holder” or collectively, the “Holders”). The Company and the Holders are referred to each as a “Party” and collectively herein as the “Parties.”
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 29th, 2021 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS SECURITIES PURCHASE AGREEMENT (together with all Exhibits and Schedules hereto, as each may be amended, restated, amended and restated, supplemented or otherwise modified from time to time in accordance with the terms hereof, this “Agreement”), dated as of October 28, 2021, is made by and among (i) Armata Pharmaceuticals, Inc., a Washington corporation (the “Company”), (ii) Cystic Fibrosis Foundation, a Delaware corporation (“CFF”) and (iii) Innoviva Strategic Opportunities LLC, a Delaware limited liability company (“Innoviva” and together with CFF, each a “Purchaser” and collectively, the “Purchasers”). The Company and the Purchasers are referred to herein individually as a “Party”, and, collectively as the “Parties.”
AMENDED AND RESTATED VOTING AGREEMENTVoting Agreement • October 29th, 2021 • Armata Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This AMENDED AND RESTATED VOTING AGREEMENT (this “Agreement”) is made and entered into as of October 28, 2021 (the “Effective Date”), by and between Armata Pharmaceuticals Inc., a Washington corporation (the “Company”), Innoviva, Inc., a Delaware corporation (“Innoviva”) and Innoviva Strategic Opportunities LLC (a Delaware limited liability company and wholly-owned subsidiary of Innoviva, “Strategic Opportunities” and together with Innoviva, the “Stockholders”).
